Standard

Efficacy of resveratrol in the treatment of unipolar depression : double-blind randomized placebo-controlled parallel-group study. / Aftanas, L. I.; Markov, A. A.; Rikita, M. V. et al.

In: European Neuropsychopharmacology, Vol. 40, 11.2020, p. S189-S189.

Research output: Contribution to journalMeeting Abstractpeer-review

Harvard

APA

Vancouver

Aftanas LI, Markov AA, Rikita MV, Danilenko KV. Efficacy of resveratrol in the treatment of unipolar depression: double-blind randomized placebo-controlled parallel-group study. European Neuropsychopharmacology. 2020 Nov;40:S189-S189. doi: 10.1016/j.euroneuro.2020.09.248

Author

Aftanas, L. I. ; Markov, A. A. ; Rikita, M. V. et al. / Efficacy of resveratrol in the treatment of unipolar depression : double-blind randomized placebo-controlled parallel-group study. In: European Neuropsychopharmacology. 2020 ; Vol. 40. pp. S189-S189.

BibTeX

@article{1c2cd9172d6e48028551f46c1deeae87,
title = "Efficacy of resveratrol in the treatment of unipolar depression: double-blind randomized placebo-controlled parallel-group study",
author = "Aftanas, {L. I.} and Markov, {A. A.} and Rikita, {M. V.} and Danilenko, {K. V.}",
year = "2020",
month = nov,
doi = "10.1016/j.euroneuro.2020.09.248",
language = "English",
volume = "40",
pages = "S189--S189",
journal = "European Neuropsychopharmacology",
issn = "0924-977X",
publisher = "Elsevier Science B.V.",
note = "33rd Congress of the European-College-of-Neuropsychopharmacology (ECNP) ; Conference date: 12-09-2020 Through 15-09-2020",

}

RIS

TY - JOUR

T1 - Efficacy of resveratrol in the treatment of unipolar depression

T2 - 33rd Congress of the European-College-of-Neuropsychopharmacology (ECNP)

AU - Aftanas, L. I.

AU - Markov, A. A.

AU - Rikita, M. V.

AU - Danilenko, K. V.

PY - 2020/11

Y1 - 2020/11

U2 - 10.1016/j.euroneuro.2020.09.248

DO - 10.1016/j.euroneuro.2020.09.248

M3 - Meeting Abstract

VL - 40

SP - S189-S189

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

SN - 0924-977X

Y2 - 12 September 2020 through 15 September 2020

ER -

ID: 27358675